MetaCap

Fractyl Health (GUTS) vs PAVmed (PAVM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

PAVmed (PAVM) has outperformed Fractyl Health (GUTS) over the past year, losing 88.8% versus a loss of 95.1%. Fractyl Health is the larger company by market cap ($10.9 million vs $9.1 million), about 1.2 times the size, while PAVmed is growing revenue faster (-97.6% vs -100.0%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GUTS-95.12%PAVM-88.77%
+78%-13%-103%
Nov 21, 20251 yearNov 20, 2026
GUTS-99.47%PAVM-98.15%
+41%-33%-106%
Jan 29, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GUTS versus PAVM key metrics
MetricGUTSPAVM
Share price$0.82$1.14
Market cap$10.88M$9.08M
1-day change-14.16%-5.42%
YTD return-96.89%-82.88%
1-year return-95.12%-88.77%
5-year return—-99.93%
EPS (TTM)$-3.14$-7.33
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$0$71.00K
Revenue growth (YoY)-100.00%-97.63%
Net income (latest FY)$-140.95M$401.00K
Gross margin—-207.04%
Operating margin—-30712.68%
Net margin—564.79%
52-week high$29.34$28.44
52-week low$0.784$1.10
Distance from 52-week high-97.21%-96.01%
Analyst consensusstrong_buynone
Avg. price target upside+7265.85%+3115.86%
Average volume504.39K23.70K
Shares outstanding13.26M8.00M
Employees10041
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Fractyl Health

GUTS stock →

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.

Health Care · Medical/Dental Instruments · 100 employees

About PAVmed

PAVM stock →

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.

Health Care · Medical/Dental Instruments · 41 employees

GUTS vs PAVM FAQ

Which is bigger, Fractyl Health or PAVmed?

Fractyl Health (GUTS) is larger, with a market capitalization of $10.88M compared with $9.08M for PAVmed (PAVM).

Which stock has performed better over the past year, GUTS or PAVM?

PAVM returned -88.77% over the past 12 months, compared with -95.12% for GUTS (price return, excluding dividends). Past performance does not predict future results.

Are Fractyl Health and PAVmed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons